Assessment of ERBB2/HER2 Status in HER2-Equivocal Breast Cancers by FISH and 2013/2014 ASCO-CAP Guidelines

IMPORTANCE: The 2013/2014 American Society of Clinical Oncology and College of American Pathologists (ASCO-CAP) guidelines for HER2 testing by fluorescence in situ hybridization (FISH) designated an “equivocal” category (average HER2 copies per tumor cell ≥4-6 with HER2/CEP17 ratio <2.0) to be re...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:JAMA Oncol
Auteurs principaux: Press, Michael F., Seoane, Jose A., Curtis, Christina, Quinaux, Emmanuel, Guzman, Roberta, Sauter, Guido, Eiermann, Wolfgang, Mackey, John R., Robert, Nicholas, Pienkowski, Tadeusz, Crown, John, Martin, Miguel, Valero, Vicente, Bee, Valerie, Ma, Yanling, Villalobos, Ivonne, Slamon, Dennis J.
Format: Artigo
Langue:Inglês
Publié: American Medical Association 2018
Sujets:
Original Investigation
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6439848/
https://ncbi.nlm.nih.gov/pubmed/30520947
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2018.6012
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires